slender tome that sought to summarise and pass comment on early decisions under the EU's new trade mark law regime. Nearly two decades later, the world is not quite so young, but Young (D Young & Co, that is) has produced a handsome volume entitled European Trade Mark Decisions, the second edition of which has fallen into his paws. This book, well illustrated and clearly written, provides in pocket-book format a handy and attractively-illustrated summary of not only the main decisions of the Court of Justice of the European Union on Community and national trade mark matters, but also a selection of some of the more important General Court decisions -- around 200 pages worth. Authorship has been split between a team of 17 contributors, the list of which contains an assortment of Katfriends and blog readers. If you are not already reviewing it or scrounging a copy from the firm, you can buy it for £60 on Amazon, here.
"Scientists have long used patents to protect their inventions and allow them opportunities to commercialise their work. However, recent attempts to patent human gene sequences have raised questions over whether a sequence of DNA is an invention or a discovery and highlighted some of the challenges in assessing the patentability of biomedical developments. Proponents argue that we need biomedical patents to provide the incentive for innovation but others believe that they could stifle scientific progress. Recent controversies in cancer and stem cell research have highlighted the social and ethical, as well as the economic implications of biomedical patents".If you are thinking of attending, the date is Tuesday 4 March 2014, from 6 pm to 8.30 pm in the Terrace Restaurant, and admission costs just £5. Full details can be found here. -- and while you are in the vicinity, why not enjoy the "Beautiful Science" exhibition, here? A katpat to James Heald for letting us know.
Lisa Mueller, an IP attorney with US practice Michael Best & Friedrich in Chicago, has recently started the BRIC Wall. a blog that promises to focus on IP developments in based on but not limited to Brazil, Russia, India and China. The emphasis will be on the chemical and life science areas, and therefore on patents too. We wish Lisa the best of luck! Elsewhere, over on PatLit David Berry has posted a handsome piece on the latest US jurisprudence on de novo review standard for revisiting a District Court's efforts at patent claim interpretation, while on IP Tango Patricia Covarrubia observes that INDECOPI, the Peruvian IP Institute, seems to be more than usually sensitive to piracy issues as the launch of a major Peruvian movie and the country's first "psychological thriller", El Vientre ("The Womb") approaches. Finally, on Class 46 Laetitia Lagarde explains the parameters of goodwill of the English word "free" in a General Court tussle between Czech and French brand owners.
|FICPI's logo looks|
a bit like this ...